Drugs that contain Lacosamide

1. Drug name - VIMPAT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE38551 UCB INC Anticonvulsant enantiomeric amino acid derivatives
Mar, 2022

(8 months ago)

Exclusivity Exclusivity Expiration
New Indication (I) Nov 16, 2023
New Patient Population (NPP) Oct 14, 2024

Market Authorisation Date: 28 October, 2008

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
200MG/20ML (10MG/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in